Bahl & Gaynor’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $926K | Sell |
8,934
-550
| -6% | -$62.4K | ﹤0.01% | 242 |
|
|
2025
Q4 | $956K | Hold |
9,484
| – | – | ﹤0.01% | 238 |
|
|
2025
Q3 | $1.17M | Sell |
9,484
-800
| -8% | -$99.3K | 0.01% | 226 |
|
|
2025
Q2 | $1.23M | Sell |
10,284
-42
| -0.4% | -$5.6K | 0.01% | 227 |
|
|
2025
Q1 | $1.52M | Sell |
10,326
-348
| -3% | -$53.1K | 0.01% | 218 |
|
|
2024
Q4 | $1.73M | Sell |
10,674
-120
| -1% | -$19.6K | 0.01% | 210 |
|
|
2024
Q3 | $1.76M | Sell |
10,794
-2,612
| -19% | -$387K | 0.01% | 217 |
|
|
2024
Q2 | $1.83M | Sell |
13,406
-3,065
| -19% | -$426K | 0.01% | 211 |
|
|
2024
Q1 | $2.52M | Sell |
16,471
-153
| -0.9% | -$22.8K | 0.01% | 197 |
|
|
2023
Q4 | $2.37M | Sell |
16,624
-278
| -2% | -$37.1K | 0.01% | 194 |
|
|
2023
Q3 | $2.22M | Buy |
16,902
+246
| +1% | +$37.4K | 0.01% | 196 |
|
|
2023
Q2 | $2.65M | Sell |
16,656
-63
| -0.4% | -$10.2K | 0.02% | 189 |
|
|
2023
Q1 | $2.65M | Sell |
16,719
-68
| -0.4% | -$10.2K | 0.01% | 198 |
|
|
2022
Q4 | $2.36M | Buy |
16,787
+903
| +6% | +$128K | 0.01% | 197 |
|
|
2022
Q3 | $2.04M | Sell |
15,884
-700
| -4% | -$101K | 0.01% | 205 |
|
|
2022
Q2 | $2.34M | Sell |
16,584
-2,052
| -11% | -$293K | 0.02% | 209 |
|
|
2022
Q1 | $2.59M | Sell |
18,636
-1,600
| -8% | -$245K | 0.02% | 201 |
|
|
2021
Q4 | $3.53M | Hold |
20,236
| – | – | 0.02% | 190 |
|
|
2021
Q3 | $3.35M | Sell |
20,236
-1,500
| -7% | -$258K | 0.02% | 189 |
|
|
2021
Q2 | $3.91M | Hold |
21,736
| – | – | 0.02% | 182 |
|
|
2021
Q1 | $4.19M | Sell |
21,736
-500
| -2% | -$96.2K | 0.03% | 179 |
|
|
2020
Q4 | $4.49M | Sell |
22,236
-15
| -0.1% | -$3.1K | 0.03% | 166 |
|
|
2020
Q3 | $4.68M | Hold |
22,251
| – | – | 0.03% | 146 |
|
|
2020
Q2 | $4.88M | Hold |
22,251
| – | – | 0.04% | 139 |
|
|
2020
Q1 | $3.85M | Sell |
22,251
-1,500
| -6% | -$248K | 0.03% | 146 |
|
|
2019
Q4 | $3.65M | Sell |
23,751
-1,240
| -5% | -$185K | 0.03% | 177 |
|
|
2019
Q3 | $3.79M | Hold |
24,991
| – | – | 0.03% | 165 |
|
|
2019
Q2 | $3.83M | Sell |
24,991
-200
| -0.8% | -$30.6K | 0.03% | 165 |
|
|
2019
Q1 | $4.04M | Hold |
25,191
| – | – | 0.04% | 147 |
|
|
2018
Q4 | $3.88M | Hold |
25,191
| – | – | 0.04% | 135 |
|
|
2018
Q3 | $3.79M | Hold |
25,191
| – | – | 0.05% | 145 |
|
|
2018
Q2 | $3.41M | Sell |
25,191
-30
| -0.1% | -$3.7K | 0.04% | 162 |
|
|
2018
Q1 | $3.36M | Sell |
25,221
-1,945
| -7% | -$261K | 0.04% | 152 |
|
|
2017
Q4 | $4.04M | Sell |
27,166
-395
| -1% | -$53.7K | 0.04% | 135 |
|
|
2017
Q3 | $3.64M | Sell |
27,561
-175
| -0.6% | -$23.5K | 0.04% | 137 |
|
|
2017
Q2 | $3.7M | Sell |
27,736
-916
| -3% | -$124K | 0.04% | 132 |
|
|
2017
Q1 | $3.86M | Sell |
28,652
-127
| -0.4% | -$16.5K | 0.04% | 130 |
|
|
2016
Q4 | $3.45M | Sell |
28,779
-437
| -1% | -$51.5K | 0.04% | 139 |
|
|
2016
Q3 | $3.66M | Sell |
29,216
-733
| -2% | -$96K | 0.04% | 127 |
|
|
2016
Q2 | $4.14M | Buy |
29,949
+622
| +2% | +$80.7K | 0.05% | 118 |
|
|
2016
Q1 | $3.7M | Sell |
29,327
-150
| -0.5% | -$19.1K | 0.05% | 123 |
|
|
2015
Q4 | $3.74M | Sell |
29,477
-1,597
| -5% | -$198K | 0.05% | 126 |
|
|
2015
Q3 | $3.59M | Sell |
31,074
-6,767
| -18% | -$760K | 0.05% | 133 |
|
|
2015
Q2 | $3.94M | Buy |
37,841
+1,630
| +5% | +$176K | 0.05% | 128 |
|
|
2015
Q1 | $4M | Buy |
36,211
+245
| +0.7% | +$26.6K | 0.05% | 127 |
|
|
2014
Q4 | $3.75M | Sell |
35,966
-1,555
| -4% | -$155K | 0.05% | 131 |
|
|
2014
Q3 | $3.6M | Buy |
37,521
+2,857
| +8% | +$258K | 0.05% | 127 |
|
|
2014
Q2 | $3.17M | Buy |
34,664
+78
| +0.2% | +$6.99K | 0.05% | 139 |
|
|
2014
Q1 | $3.04M | Buy |
34,586
+666
| +2% | +$58.5K | 0.05% | 142 |
|
|
2013
Q4 | $3.15M | Buy |
33,920
+540
| +2% | +$48.6K | 0.05% | 137 |
|
|
2013
Q3 | $2.73M | Buy |
33,380
+400
| +1% | +$33.8K | 0.05% | 138 |
|
|
2013
Q2 | $2.74M | Buy |
+32,980
| New | +$2.84M | 0.05% | 137 |
|
Other funds holding CLX
VCM
VPM
DAM
Bahl & Gaynor's CLX Position: Q1 2026 in Review
Bahl & Gaynor reduced its Clorox (CLX) stake by 5.8% in Q1 2026, selling an estimated $62.4K and leaving 8,934 shares worth $926K. The position accounts for ﹤0.01% of the portfolio, ranked #242.
Bahl & Gaynor first reported a position in CLX in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.88M in Q2 2020. 1,084 funds tracked by Wall St. Rank hold CLX as of Q1 2026.
- Bahl & Gaynor held 8,934 shares of Clorox worth $926K as of Q1 2026.
- Bahl & Gaynor sold 550 Clorox shares in Q1 2026, an estimated $62.4K.
- Clorox made up ﹤0.01% of Bahl & Gaynor's portfolio in Q1 2026, its #242 holding.
- Bahl & Gaynor first reported a position in Clorox in Q2 2013 and has held it in 52 quarters since.
- Bahl & Gaynor's Clorox position peaked at $4.88M in Q2 2020.
- 1,084 funds tracked by Wall St. Rank held Clorox as of Q1 2026.
Based on Bahl & Gaynor's 13F filing for Q1 2026, filed 7 May 2026.